Viacom, Inc. (VIAB), CBS Corporation (CBS): Why This Entertainment Content Business Looks Like a Buy

Page 1 of 2

Since the beginning of the year, Viacom, Inc. (NASDAQ:VIAB) has delivered a sweet gain for its shareholders, up by more than 50% and handily beating the S&P 500’s return of nearly 20%. Recently, it experienced a significant gain of nearly 6.5% in a single day due to its impressive third-quarter results and its plan to return cash to shareholders.

Impressive second-quarter earnings growth

In the third quarter, its revenue increased around 14% to nearly $3.7 billion, thanks to growth in the Media Networks and the Filmed Entertainment segment. Its operating income growth came in at as much as 20%, to nearly $1.09 billion, due to a higher Media Networks affiliate fees and advertising revenue, which more than offset the higher cost in Filmed Entertainment distribution. Its diluted EPS from continuing operations was $1.32, 33% higher than the same period last year.

Philippe Dauman, Viacom, Inc. (NASDAQ:VIAB)’s President and CEO, mentioned that the solid affiliate revenue gains were due to the expansion of the partnership with traditional cable operators and new digital distributions. He commented further: “In a crowded summer season, Paramount’s tentpoles – Star Trek Into Darkness and World War Z – achieved critical and box office success, and the studio has a promising slate remaining through calendar 2013 and beyond.”

A huge share buyback

The market values Viacom, Inc. (NASDAQ:VIAB) at around 11.25 times its trailing EBITDA (earnings before interest, taxes, depreciation, and amortization). At the current trading price, Viacom offers its shareholders a dividend yield of 1.6%, with a payout ratio of 33%. Income investors might also like its huge share buyback program. Recently, the company announced an increase in its Class B stock repurchase program, from $10 billion to $20 billion. Thus, investors would be entitled to as much as 52% buyback yield in total.

In 2005, Viacom, Inc. (NASDAQ:VIAB) split itself into two different businesses: Viacom and CBS Corporation (NYSE:CBS). CBS is the owner of the struggling radio business and slow growing broadcast network, and Viacom owned the MTV’s fast growing cable networks and Paramount Studios. Famous investment manager Mario Gabelli likes Viacom a lot. He mentioned that while CBS was doing quite well under Les Moonves’ leadership, Viacom is better under the leadership of Tom Dooley and Philippe Dauman. Mario Gabelli believes that the company might reach $100 per share within just three years.

CBS and Time Warner have a cheaper valuation

CBS Corporation (NYSE:CBS) has a bit cheaper valuation than Viacom, Inc. (NASDAQ:VIAB). The market values CBS at 10.8 times its trailing EBITDA. In the second quarter, CBS also managed to deliver decent growth. Its revenue increased from $3.33 billion in the second quarter of 2012 to nearly $3.7 billion in the second quarter this year, while net earnings jumped more than 10.5%. EPS came in at $0.76. CBS offers a lower dividend yield than Viacom, at 0.90%, with a lower payout ratio of 18%. The company also returns cash to shareholders via share repurchases. Recently, it increased its share repurchase authorization by $5.1 billion to around $6 billion, yielding as much as 18% in buyback activities.

Another peer, Time Warner Cable Inc (NYSE:TWC), also has a lower valuation than Viacom, Inc. (NASDAQ:VIAB). The market values Time Warner at 10.2 times its trailing EBITDA. Time Warner derives most of its revenue from video, high-speed data and video services to both business and residential customers.

According to Fitch, the company intends to have a better balance between profitability and subscriber quality, including subscriber growth and volume metrics. The company will focus on attracting higher quality subscribers to generate better residential business retention rates. With the new pricing architecture in 2013, the company expects to have a more stable customer base while relying less on promotional pricing.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!